CA-44-LT45_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 4-(3,4-Dichlorophenyl)-5-(4-pyridinyl)-2-thiazolamine, Adenosine A2B Antagonists;p38 MAPK Inhibitors;Adenosine A1 Antagonists;Phosphodiesterase IV Inhibitors;Adenosine A3 Antagonists targeting ADORA1, ADORA2B, ADORA3, PDE2A, MAPK13 (Novartis, 5282339)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/5282339
Similar Terms
Downloads & Tools

Genes

16 genes differentially expressed following the CA-44-LT45_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
SCNN1A sodium channel, non voltage gated 1 alpha subunit 1.75384
SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 1.3915
DAD1 defender against cell death 1 1.36591
MYL2 myosin, light chain 2, regulatory, cardiac, slow 1.24373
MT2A metallothionein 2A 1.18
SPCS1 signal peptidase complex subunit 1 homolog (S. cerevisiae) 1.15741
RPS18 ribosomal protein S18 0.696851
PER1 period circadian clock 1 0.503485
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.320283
PHACTR3 phosphatase and actin regulator 3 0.28186
RNF138 ring finger protein 138, E3 ubiquitin protein ligase 0.218913
GADD45B growth arrest and DNA-damage-inducible, beta 0.203678

decreased expression

Symbol Name Standardized Value
KRT17 keratin 17, type I -0.422082
S100A2 S100 calcium binding protein A2 -0.293583
MAF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog -0.28186
IL32 interleukin 32 -0.236922